Halozyme Therapeutics Inc. buy Wells Fargo & Company
Start price
07.06.24
/
50%
€47.16
Target price
07.06.25
€53.56
Performance (%)
14.38%
Price
04.10.24
€53.94
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan currently has a performance of 14.38%. This prediction currently runs until 07.06.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Halozyme Therapeutics Inc. | 5.765% | 5.765% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at Wells Fargo & Company from $48.00 to $58.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat